Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: November 3, 2025, 10:03 pm
Author: Getaka|Social: XLinkedIn

SMS Lifesciences India Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹1,158.40Fairly Valued by 3.22%vs CMP ₹1,197.00

P/E (20.6) × ROE (10.8%) × BV (₹650.00) × DY (0.13%)

₹776.07Overvalued by 35.17%vs CMP ₹1,197.00
MoS: -54.2% (Negative)Confidence: 58/100 (Moderate)Models: 1 Under, 1 Fair, 7 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹1,073.0523%Over (-10.4%)
Graham NumberEarnings₹913.9916%Over (-23.6%)
Earnings PowerEarnings₹32.9711%Over (-97.2%)
DCFCash Flow₹240.7014%Over (-79.9%)
Net Asset ValueAssets₹660.537%Over (-44.8%)
EV/EBITDAEnterprise₹1,321.069%Under (+10.4%)
Earnings YieldEarnings₹571.207%Over (-52.3%)
ROCE CapitalReturns₹1,009.777%Over (-15.6%)
Revenue MultipleRevenue₹1,156.765%Fair (-3.4%)
Consensus (9 models)₹776.07100%Overvalued
Key Drivers: Wide model spread (₹33–₹1,321) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -7.4%

*Investments are subject to market risks

Investment Snapshot

54
SMS Lifesciences India Ltd scores 54/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health61/100 · Moderate
ROCE 11.8% AverageROE 10.8% AverageD/E 0.45 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money60/100 · Moderate
FII holding up 0.01% (6mo) Slight increasePromoter holding at 71.4% Stable
Earnings Quality60/100 · Moderate
OPM stable around 12% SteadyWorking capital: 7 days (improving) Efficient
Quarterly Momentum30/100 · Weak
Revenue (4Q): 3% YoY FlatProfit (4Q): -7% YoY DecliningOPM: 14.2% (down 3.4% YoY) Margin pressure
Industry Rank55/100 · Moderate
P/E 20.6 vs industry 53.8 Cheaper than peersROCE 11.8% vs industry 16.4% Average3Y sales CAGR: 0% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 10:03 pm

Market Cap 357 Cr.
Current Price 1,197
Intrinsic Value₹776.07
High / Low 1,680/956
Stock P/E20.6
Book Value 650
Dividend Yield0.13 %
ROCE11.8 %
ROE10.8 %
Face Value 10.0
PEG Ratio-2.80

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for SMS Lifesciences India Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
SMS Lifesciences India Ltd 357 Cr. 1,197 1,680/95620.6 6500.13 %11.8 %10.8 % 10.0
Albert David Ltd 352 Cr. 616 959/58036.6 6900.81 %6.45 %4.39 % 10.0
Bafna Pharmaceuticals Ltd 265 Cr. 112 205/70.623.1 38.60.00 %8.34 %7.69 % 10.0
Kilitch Drugs (India) Ltd 484 Cr. 138 250/11718.6 75.90.00 %15.7 %12.6 % 10.0
BDH Industries Ltd 219 Cr. 381 524/24121.0 1231.18 %17.8 %14.2 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of SMS Lifesciences India Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 82.2881.2688.2963.7374.6569.2672.0589.9992.5578.4684.6089.1182.50
Expenses 73.7972.9978.9261.4572.1161.3362.7578.6376.2769.8971.8581.6970.79
Operating Profit 8.498.279.372.282.547.939.3011.3616.288.5712.757.4211.71
OPM % 10.32%10.18%10.61%3.58%3.40%11.45%12.91%12.62%17.59%10.92%15.07%8.33%14.19%
Other Income 0.310.150.494.810.610.270.582.360.442.040.062.341.00
Interest 1.641.681.671.802.182.812.342.842.402.142.142.031.87
Depreciation 2.592.642.632.923.703.733.733.783.683.763.763.803.82
Profit before tax 4.574.105.562.37-2.731.663.817.1010.644.716.913.937.02
Tax % 49.23%23.66%31.29%10.55%40.29%126.51%-8.14%8.73%33.27%29.72%29.81%11.45%37.61%
Net Profit 2.323.123.822.11-3.83-0.444.126.477.103.304.863.484.39
EPS in Rs 9.969.1013.205.66-5.952.2514.2219.5223.1515.4518.099.8213.76

Last Updated: August 20, 2025, 3:25 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:25 am

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 378261266350316306345335
Expenses 343235235316287275300294
Operating Profit 3525303529314540
OPM % 9%10%11%10%9%10%13%12%
Other Income 222145455
Interest 655671098
Depreciation 6881011151515
Profit before tax 2515203317102623
Tax % 30%31%31%23%31%36%28%
Net Profit 181014251161916
EPS in Rs 59.0433.6744.8583.7537.9130.0766.5257.12
Dividend Payout % 3%0%3%2%4%5%2%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-44.44%40.00%78.57%-56.00%-45.45%216.67%
Change in YoY Net Profit Growth (%)0.00%84.44%38.57%-134.57%10.55%262.12%

SMS Lifesciences India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:6%
3 Years:-1%
TTM:3%
Compounded Profit Growth
10 Years:%
5 Years:15%
3 Years:8%
TTM:-3%
Stock Price CAGR
10 Years:%
5 Years:20%
3 Years:17%
1 Year:-30%
Return on Equity
10 Years:%
5 Years:9%
3 Years:8%
Last Year:11%

Last Updated: September 5, 2025, 1:31 pm

Balance Sheet

Last Updated: October 10, 2025, 2:59 pm

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 3333333
Reserves 103113126149166174194
Borrowings 4765658010010186
Other Liabilities 11672108125126114107
Total Liabilities 270253302357395391390
Fixed Assets 118124130142228223232
CWIP 3163851160
Investments 0000000
Other Assets 148113134164166162158
Total Assets 270253302357395391390

Reserves and Borrowings Chart

Cash Flow - No data available for this post.

Free Cash Flow

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-12.00-40.00-35.00-45.00-71.00-70.00-41.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 40304735536173
Inventory Days 116149164159184196160
Days Payable 140101163146127143126
Cash Conversion Cycle 16784848110115106
Working Capital Days 141821724117
ROCE %12%13%12%8%7%12%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Promoters 69.85%70.32%70.32%70.32%70.32%70.68%71.19%71.40%71.40%71.40%71.40%71.40%
FIIs 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.02%0.00%0.00%0.03%
Public 30.14%29.69%29.67%29.68%29.68%29.31%28.81%28.59%28.57%28.59%28.60%28.56%
No. of Shareholders 8,7998,5938,3498,4758,4438,2338,1167,8617,8497,6267,4797,412

Shareholding Pattern Chart

No. of Shareholders

SMS Lifesciences India Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 66.5130.0837.9283.6144.84
Diluted EPS (Rs.) 66.5130.0837.9283.6144.84
Cash EPS (Rs.) 111.5670.3473.32116.7870.84
Book Value[Excl.RevalReserv]/Share (Rs.) 650.15640.48622.55545.53427.40
Book Value[Incl.RevalReserv]/Share (Rs.) 650.15640.48622.55545.53427.40
Revenue From Operations / Share (Rs.) 1140.221012.001043.761156.83878.48
PBDIT / Share (Rs.) 165.05115.57105.27119.80105.71
PBIT / Share (Rs.) 115.4466.1669.5886.7079.70
PBT / Share (Rs.) 86.6332.5754.88108.2664.72
Net Profit / Share (Rs.) 61.9620.9337.6383.6844.84
NP After MI And SOA / Share (Rs.) 66.5130.0737.9183.7644.84
PBDIT Margin (%) 14.4711.4210.0810.3512.03
PBIT Margin (%) 10.126.536.667.499.07
PBT Margin (%) 7.593.215.259.357.36
Net Profit Margin (%) 5.432.063.607.235.10
NP After MI And SOA Margin (%) 5.832.973.637.245.10
Return on Networth / Equity (%) 10.235.146.7916.6310.49
Return on Capital Employeed (%) 14.078.138.0411.8412.77
Return On Assets (%) 5.152.322.907.094.48
Long Term Debt / Equity (X) 0.090.180.320.260.30
Total Debt / Equity (X) 0.420.550.580.500.45
Asset Turnover Ratio (%) 0.880.770.831.130.99
Current Ratio (X) 1.061.071.191.151.11
Quick Ratio (X) 0.580.510.540.520.56
Inventory Turnover Ratio (X) 2.021.792.003.022.24
Dividend Payout Ratio (NP) (%) 0.004.983.951.790.00
Dividend Payout Ratio (CP) (%) 0.001.882.031.280.00
Earning Retention Ratio (%) 0.0095.0296.0598.210.00
Cash Earning Retention Ratio (%) 0.0098.1297.9798.720.00
Interest Coverage Ratio (X) 5.733.444.685.877.06
Interest Coverage Ratio (Post Tax) (X) 3.151.622.333.043.99
Enterprise Value (Cr.) 424.63318.25271.04295.69197.88
EV / Net Operating Revenue (X) 1.231.040.850.840.74
EV / EBITDA (X) 8.519.118.528.166.19
MarketCap / Net Operating Revenue (X) 0.940.670.490.600.56
Retention Ratios (%) 0.0095.0196.0498.200.00
Price / BV (X) 1.661.160.931.381.16
Price / Net Operating Revenue (X) 0.940.670.490.600.56
EarningsYield 0.060.040.070.120.09

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company

SMS Lifesciences India Ltd. is a Public Limited Listed company incorporated on 31/05/2006 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L74930TG2006PLC050223 and registration number is 050223. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 345.63 Cr. and Equity Capital is Rs. 3.02 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsPlot No.19-III, Road No.71, Hyderabad Telangana 500096info@smslife.in
http://www.smslife.in
Management
NamePosition Held
Mr. TVVSN MurthyManaging Director
Mr. T V PraveenExecutive Director
Mrs. Sudeepthi GopineediWhole Time Director
Mr. P Sarath KumarIndependent Director
Dr. Srinivas SamavedamIndependent Director
Dr. Mannam MalakondaiahIndependent Director

SMS Lifesciences India Ltd. Share Price Update

Share PriceValue
Today₹660.60
Previous Day₹657.35

FAQ

What is the intrinsic value of SMS Lifesciences India Ltd and is it undervalued?

As of 16 April 2026, SMS Lifesciences India Ltd's intrinsic value is ₹776.07, which is 35.17% lower than the current market price of ₹1,197.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (10.8 %), book value (₹650), dividend yield (0.13 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of SMS Lifesciences India Ltd?

SMS Lifesciences India Ltd is trading at ₹1,197.00 as of 16 April 2026, with a FY2026-2027 high of ₹1,680 and low of ₹956. The stock is currently in the middle of its 52-week range. Market cap stands at ₹357 Cr..

How does SMS Lifesciences India Ltd's P/E ratio compare to its industry?

SMS Lifesciences India Ltd has a P/E ratio of 20.6, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is SMS Lifesciences India Ltd financially healthy?

Key indicators for SMS Lifesciences India Ltd: ROCE of 11.8 % is moderate. Dividend yield is 0.13 %.

Is SMS Lifesciences India Ltd profitable and how is the profit trend?

SMS Lifesciences India Ltd reported a net profit of ₹19 Cr in Mar 2025 on revenue of ₹345 Cr. Compared to ₹25 Cr in Mar 2022, the net profit shows a declining trend.

Does SMS Lifesciences India Ltd pay dividends?

SMS Lifesciences India Ltd has a dividend yield of 0.13 % at the current price of ₹1,197.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in SMS Lifesciences India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports